- Topics, Trends & Updates for June (6/2/22)
- Updated: PrEP to Prevent HIV and Promote Sexual Health (5/23/22)
- Updated: HIV Testing (5/20/22)
- New Guidance: Adopting a Patient-Centered Approach to Sexual Health (4/28/22)
- New Guidance: Questions, Answers, and Best Practices for Expedited Partner Therapy (EPT) (4/19/22)
- Updated: Use of Injectable CAB/RPV LA as Replacement ART in Virally Suppressed Adults (4/7/22)
- Updated: Screening for Cervical Dysplasia and Cancer in Adults With HIV (3/29/22)
- Updated: Mycoplasma genitalium Management in Adults (3/28/22)
- Updated: Screening for Anal Dysplasia and Cancer in Adults With HIV (2/22/22)
- New Guideline: Therapeutic Use of Medical Cannabis in New York State (1/25/22)
- Updated: COVID-19 Vaccine for Adults With HIV (1/12/22)
- Updated: Perioperative Care in Adults With HIV (11/16/21)
- Updated: Selecting An Initial ART Regimen (10/11/21)
- Updated: When to Initiate ART, With Protocol for Rapid Initiation (10/11/21)
- Updated: Diagnosis and Management of HIV-2 in Adults (10/11/21)
- Medscape Interviews Dr. Elliot DeHaan, Lead Author of New Guideline on CAB/RPV LA (8/3/21)
- Medscape Commentary: IRIS: 'Why Is My Patient Getting Worse?' (7/29/21)
- Updated Resource: ART Drug-Drug Interactions (7/20/21)
- Updated Guideline: Diagnosis and Management of Acute HIV Infection (7/20/21)
- New Guideline: Substance Use Disorder Treatment in Pregnant Adults (7/16/21)
- New Guideline: Use of Injectable CAB/RPV LA as Replacement ART in Virally Suppressed Adults (7/14/21)
- New Recommendation: COVID-19 Vaccine for Adults With HIV (7/13/21)
- Updated Guideline: Laboratory Monitoring for Adverse Effects of ART (6/8/21)
- Updated: Use of Dolutegravir in Individuals of Childbearing Capacity (6/3/21)
- Updated Guideline: Prevention and Management of Hepatitis A Virus in Adults With HIV (5/21/21)
- NYCDOHMH: CDC Expands Recommendation for COVID-19 Vaccination to Children Aged 6 Months to 5 Years (6/23/22)
- FDA Authorizes Moderna and Pfizer-BioNTech COVID-19 Vaccines for Children Down to 6 Months of Age (6/17/22)
- NYCDOHMH: Addressing Long COVID (6/8/22)
- NYCDOHMH: Update on COVID-19 Booster Doses (5/21/22)
- FDA Expands Eligibility for Pfizer-BioNTech COVID-19 Vaccine Booster Dose to Children 5 through 11 Years (5/17/22)
- FDA Authorizes First COVID-19 Test Available without a Prescription That Also Detects Flu and RSV (5/16/22)
- HIVinfo Releases New HIV and COVID-19 Fact Sheet (5/12/22)
- FDA Limits Use of Janssen COVID-19 Vaccine to Certain Individuals (5/5/22)
- FDA Approves First COVID-19 Treatment for Young Children (4/25/22)
- FDA Authorizes First COVID-19 Diagnostic Test Using Breath Samples (4/14/22)
- NYCDOHMH: CDC Allows Second COVID-19 Boosters for Certain People (3/31/22)
- FDA Authorizes Second Booster Dose of Two COVID-19 Vaccines for Older and Immunocompromised Individuals (3/29/22)
- NYCDOHMH: Updated COVID-19 Vaccination Interval Guidance (3/1/22)
- NYCDOHMH: COVID-19 Vaccine Updates (2/18/22)
- FDA Takes Key Action by Approving Second COVID-19 Vaccine (1/31/22)
- FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant (1/24/22)
- FDA Takes Actions to Expand Use of Treatment for Outpatients with Mild-to-Moderate COVID-19 (1/21/22)
- Free At-Home COVID-19 Tests (1/19/22)
- FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months (1/7/22)
- FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine (1/3/22)
- NYCDOHMH: mRNA COVID-19 Vaccines Preferred Over Johnson & Johnson (12/23/21)
- FDA EUA for Paxlovid for COVID-19 (12/23/21)
- NYCDOHMH: COVID-19 Boosters Recommended for People Ages 16 and 17 Years (12/16/21)
- FDA Expands Eligibility for Pfizer-BioNTech COVID-19 Booster Dose to 16- and 17-Year-Olds (12/9/21)
- NYCDOHMH: CDC Recommends All Adults May Receive a COVID-19 Booster Dose (11/24/21)
- AETC NCRC: Quarterly Newsletter - Summer 2022 (6/22/22)
- CEI Newsletter (6/22/22)
- NYSDOH Health Advisory: Monkeypox Outbreak, United States (6/21/22)
- CDC: Monkeypox Information and Guidance (6/15/22)
- CDC: Social Gatherings, Safer Sex and Monkeypox (6/15/22)
- National Coalition of STD Directors: Monkeypox Command Center (6/15/22)
- NYSDOH Update: Monkeypox in New York State June 2022 (6/15/22)
- NYSDOH AI: Mark Your Calendars for the Fourth Annual PrEP Aware Week (6/14/22)
- NYSDOH: Telehealth Consumer Survey (6/8/18)
- NYS Medicaid Update – May (6/6/22)
- CEI Interview: Drs. Vail and Urban Discuss the Updated NYSDOH AI PrEP Guideline (6/6/22)
- NYSDOH: STI Self-Collection Outside of a Clinic Setting Q & A (6/6/22)
- NYSDOH Health Advisory: Monkeypox cases not associated with travel to areas where monkeypox is enzootic (5/23/22)
- CDC Health Advisory: Monkeypox Virus Infection in the United States and Other Non-endemic Countries—2022 (5/20/22)
- HIVinfo: Updated Resources Available: FDA-Approved HIV Medicines (5/16/22)
- NYSDOH: Hepatitis C (HCV) Dashboard Launches (5/2/22)
- HIVinfo: Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV (4/12/22)
- HIVinfo: Updated HHS Pediatric Antiretroviral Therapy Guidelines Released (4/12/22)
- 2022 AIDS Institute Director Call to Action Letter (3/15/22)
- Now Available: Enhanced Access to STI Clinical Experts Through the CEI Sexual Health Center of Excellence (3/10/22)
- Key Changes in Cannabis Policies: Passage of the Marijuana Regulation and Taxation Act (3/9/22)
- HIVinfo: What’s New in the COVID-19 and HIV Guidance (2/22/22)
- HIVinfo: Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV (2/17/22)
- HIVinfo: Updated Resources Available: HIV and Opportunistic Infections, Coinfections, and Conditions (1/26/22)
- NYSDOH AI Letter from the Director: Increase of Congenital Syphilis in NYS (1/25/22)
- 07/05/2022: HepCure & HCV and Drug User Health COE: Hepatitis C in Children and Adolescents
- 07/05/2022: HCV and Drug User Health COE: Harm Reduction Training Series: Harm Reduction for Health Care Providers
- 07/11/2022: HCV and Drug User Health COE: Harm Reduction Training Series: Innovating Models of Primary Care for People who Use Drugs
- 07/13/2022: HIV Primary Care and Prevention COE: PrEP for Adolescents and Young Adults
- 07/18/2022: HIV Primary Care and Prevention COE: Pre-Exposure Prophylaxis (PrEP): Updated NYS 2022 PrEP Guidelines
- 07/19/2022: HCV and Drug User Health COE: Harm Reduction Training Series: Substance Use, Pregnancy and Parenting: A Harm Reduction Approach
- 07/19/2022: HIV Primary Care and Prevention COE: PrEP for Older Adults
- 07/27/2022: HCV and Drug User Health COE: Harm Reduction Training Series: Safer Injection Drug Use
- 08/02/2022: HCV and Drug User Health COE: Harm Reduction Training Series: Antiracism and Harm Reduction
- 07/01/2022: NAHEWD: Bridging HIV & SUD: Innovations in the Field: Methamphetamines, MSMs, and HIV
- 07/29/2022: AIDS 2022 (The 24th International AIDS Conference)
- 08/11/2022: MA AETC: Partnership: Why it Matters and How to Build It
- 08/23/2022: HRSA HAB: National Ryan White Conference on HIV Care & Treatment
- 08/30/2022: MA AETC: Ending the HIV Epidemic: Implementing Substance Use, Mental Health, HCV and STI Screening
- 09/09/2022: NEAETC: 18th Annual Conference on HIV/AIDS & Aging
- 10/16/2022: IAS-USA: 2022 Ryan White HIV/AIDS Program Clinical Conference
- 10/24/2022: NYSDOH AI: PrEP Aware Week